857
Views
0
CrossRef citations to date
0
Altmetric
Review

A Missing Piece in the Puzzle: HIV in Mature Adults in Sub-Saharan Africa

&
Pages 755-767 | Published online: 09 Jun 2011

Bibliography

  • Murray C , LopezA: Mortality by cause for eight regions of the world: Global Burden of Disease Study.Lancet349 , 1269–1276 (1997).
  • Wallrauch C , BarnighausenT, Newell M-L: HIV infection of concern also in people 50 years and older in rural South Africa. S. Afr. Med. J.100(12) , 821–824 (2010).
  • Schmid GP , WilliamsBG, Garcia-CallejaJM et al.: The unexplored story of HIV and aging.Bull. World Health Organ.87(3) , 162–162A (2009).
  • Pardi GR , NunesA, PretoR, CanassaP, CorreiaD: Profile of adherence to highly active antiretroviral therapy of patients older than 50 years old.J. Acquir. Immune Defic. Syndr.52(2) , 301–302 (2009).
  • Danielson ME , JusticeAC: Veterans Aging Cohort Study (VACZ) meeting summary.J. Clin. Epidemiol.54 , S9–S11 (2001).
  • Gebo KA : HIV infection in older people.BMJ338 , B1460 (2009).
  • Negin J , WarieroJ, CummingR, MutuoP, PronykP: High rates of AIDS-related mortality among older adults in rural Kenya.J. Acquir. Immune Defic. Syndr.55(2) , 239–244 (2010).
  • Negin J , CummingR: HIV infection in older adults in sub-Saharan Africa: extrapolating prevalence from existing data.Bull. World Health Organ.88 , 847–853 (2010).
  • Peltzer K , Phaswana-MafuyaN, MzoloT, TabaneC, ZumaK: Sexual behaviour, HIV status and HIV risk among older South Africans.Ethno. Med.4(3) , 163–172 (2010).
  • Schartz E , OgunmefunC: Caring an contributing: the role of older women in rural South African multi-generational households in the HIV/AIDS era.World Dev.35 , 1390–1403 (2007).
  • Mills E , RammohanA, AwofesoN: Ageing faster with AIDS in Africa.Lancet377(9772) , 1131–1133 (2011).
  • Gebo K : Epidemiology of HIV and response to antiretroviral therapy in the middle aged and elderly.Aging Health4(6) , 615–627 (2008).
  • Herbst AJ , CookeGS, BarnighausenT, KanykanyA, TanserF, NewellML: Adult mortality and antiretroviral treatment roll-out in rural KwaZulu-Natal, South Africa.Bull. World Health Organ.87(10) , 754–762 (2009).
  • Manfredi R , CalzaL, CocchiD, ChiodoF: Antiretroviral treatment and advanced age: epidemiologic, laboratory and clinical features in the elderly.J. Acquir. Immune Defic. Syndr.33(1) , 112–114 (2003).
  • Grabar S , WeissL, CostagliolaD: HIV infection in older patients in the HAART era.J. Antimicrob. Chemother.57(1) , 4–7 (2006).
  • Nguyen N , HolodniyM: HIV infection in the elderly.Clin. Intervent. Aging3(3) , 453–472 (2008).
  • Welz T , HosegoodV, JaffarS, Batzing-FeigenbaumJ, HerbstK, NewellML: Continued very high prevalence of HIV infection in rural KwaZulu-Natal, South Africa: a population-based longitudinal study.AIDS21(11) , 1467–1472 (2007).
  • Zaba B , ToddJ, BiraroS et al.: Diverse age patterns of HIV incidence in Africa. Presented at: XVII International AIDS Conference. Mexico City, Mexico, 3–8 August 2008.
  • Kohli R , KleinR, SchoenbaumE, AnastosK, MinkoffH, SacksH: Aging and HIV infection.J. Urban Health83(1) , 31–41 (2006).
  • Miles Q , BarnighausenT, TanserF, LurieM, NewellM: Age-gaps in sexual partnerships: seeing beyond ‘sugar daddies‘.AIDS25(6) , 861–863 (2011).
  • Kahn K , TollmanS, ThorogoodM et al.: Older adults and the health transition in Agincourt, rural South Africa: new understanding, growing complexity. In: Aging in sub-Saharan Africa: Recommendations for Furthering Research. Cohen B, Menken J (Eds). National Academic Press, Washington, DC, USA, 166–188 (2006).
  • Lau C , MuulaA: HIV/AIDS in sub-Saharan Africa.Croat. Med. J.45(5) , 402–414 (2004).
  • Lopez A , MathersC, EzzatiM, JamisonD, MurrayC: Measuring the global burden of disease and risk factors, 1990–2001. In: Global Burden of Disease and Risk Factors. (Eds). Oxford University Press, NY, USA, 1–13 (2006).
  • Christensen K , DoblhammerG, RauR, VaupelJ: Aging populations: the challenges ahead.Lancet374 , 1196–1208 (2009).
  • Mayosi B , FlisherA, LallooU, SitasF, TollmanS, BradshwaD: The burden on non-communicable diseases in South Africa.Lancet374 , 934–947 (2009).
  • Rhee MS , GreenblattDJ: Pharmacologic consideration for the use of antiretroviral agents in the elderly.J. Clin. Pharmacol.48(10) , 1212–1225 (2008).
  • Andrew C , DavidAC: Adverse effects of retroviral therapy.Lancet356 , 1423–1430 (2000).
  • Kyobutung C , EgondiT, EzehA: The health and wellbeing of older people in Nairobi‘s slums.Glob. Health ActionS2 , 45–53 (2010).
  • Gebo K : HIV and aging: implications for patient management.Drugs Aging23(11) , 897–913 (2006).
  • Justice AC , LandefeldCS, AschSM, GiffordAL, WhalenCC, CovinskyKE: Justification for a new cohort study of people aging with and without HIV infection.J. Clin. Epidemiol.54 , S3–S8 (2001).
  • Cuzin L , DelpierreC, GerardS, MassipP, MarchouB: Immunologic and clinical responses to highly active antiretroviral therapy in patients with HIV infection aged >50 years.Clin. Infect. Dis.45(5) , 654–657 (2007).
  • Fabian J , NaickerS: HIV and kidney disease in sub-Saharan Africa.Nat. Rev. Nephrol.5(10) , 591–598 (2009).
  • Sabin CA , SmithCJ, DelpechV et al.: The associations between age and the development of laboratory abnormalities and treatment discontinuation for reasons other than virological failure in the first year of highly active antiretroviral therapy.HIV Med.10(1) , 35–43 (2009).
  • Brinkhof MW , DabisF, MyerL et al.: Early loss of HIV-infected patients on potent antiretroviral therapy programs in lower-income countries.Bull. World Health Organ.86(7) , 559–567 (2008).
  • Etard JF , NdiayeI, Thierry-MiegM et al.: Mortality and causes of death in adults receiving highly active antiretroviral therapy in Senegal: a 7-year cohort study.AIDS20(8) , 1181–1189 (2006).
  • Babiker AG , PetoT, PorterK, WalkerAS, DarbyshireJH: Age as a determinant of survival in HIV infection.J. Clin. Epidemiol.54(Suppl. 1) , S16–S21 (2001).
  • Glynn JR , SonnenbergP, NelsonG et al.: Survival from HIV-1 seroconversion in Southern Africa: a retrospective cohort study in nearly 2000 gold-miners over 10 years of follow-up.AIDS21(5) , 625–632 (2007).
  • Eligibility for ART in Lower Income Countries (eART-LINC) Collaboration; Wandel S, Egger M, Rangsin R et al.: Duration from seroconversion to eligibility for antiretroviral therapy and from ART eligibility to death in adult HIV-infected patients from low and middle-income countries: collaborative analysis of prospective studies. Sex. Transm. Infect.84(Suppl. 1) , I31–I36 (2008).
  • Todd J , GlynnJ, MarstonM et al.: Time from HIV seroconversion to death: a collaborative analysis of eight studies in six low and middle-income countries before highly active antiretroviral therapy.AIDS21 , S55–S63 (2007).
  • Tumbarello M , RabagliatiR, De Gaetano K, Bertagnolio S, Tamburrini E, Cauda R: Older HIV-positive patients in the era of highly active antiretroviral therapy: changing of a scenario. AIDS17(1) , 128–131 (2003).
  • Lawn SD , LittleF, BekkerLG et al.: Changing mortality risk associated with CD4 cell response to antiretroviral therapy in South Africa.AIDS23(3) , 335–342 (2009).
  • Toure S , KouadioB, SeylerC et al.: Rapid scaling-up of antiretroviral therapy in 10.000 adults in Cote d‘Ivoire: 2-year outcomes and determinants.AIDS22(7) , 873–882 (2008).
  • Tuboi SH , PachecoAG, HarrisonLH et al.: Mortality associated with discordant responses to antiretroviral therapy in resource-constrained settings.J. Acquir. Immune Defic. Syndr.53(1) , 70–77 (2010).
  • Brinkhof MW , BoulleA, WeigelR et al.: Mortality of HIV-infected patients starting antiretroviral therapy in sub-Saharan Africa: comparison with HIV-unrelated mortality.PLoS Med.6(4) , E1000066 (2009).
  • Stringer JS , ZuluI, LevyJ et al.: Rapid scale-up of antiretroviral therapy at primary care sites in Zambia: feasibility and early outcomes.JAMA296(7) , 782–793 (2006).
  • The Collaboration of Observational HIV Epidemiological Research Europe (COHERE) Study Group: Response to combination antiretroviral therapy: variation by age. AIDS22(12) , 1463–1473 (2008).
  • Fairall LR , BachmannMO, LouwagieGM et al.: Effectiveness of antiretroviral treatment in a South African program: a cohort study.Arch. Intern. Med.168(1) , 86–93 (2008).
  • Brinkhof MW , Pujades-RodriguezM, EggerM: Mortality of patients lost to follow-up in antiretroviral treatment programs in resource-limited settings: systematic review and meta-analysis.PLoS One4(6) , E5790 (2009).
  • Macpherson P , MoshabelaM, MartinsonN, PronykP: Mortality and loss to follow-up among HAART initiators in rural South Africa.Trans. R. Soc. Trop. Med. Hyg.103(6) , 588–593 (2009).
  • Negin J , WarieroJ, CummingR, MutuoP, PronykP: High rates of AIDS-related mortality among older adults in rural Kenya.J. Acquir. Immune Defic. Syndr.55 , 239–244 (2010).
  • The Antiretroviral Therapy Cohort Collaboration: Causes of death in HIV-1-infected patients treated with antiretroviral therapy. Clin. Infect. Dis.50 , 1387–1396 (2010).
  • De Wit S , SabinC, WeberR et al.: Incidence and risk factors for new-onset diabetes in HIV-infected patients.Diabetes Care31 , 1224–1229 (2008).
  • Dunbar-Jacob J , Mortimer-StephensMK: Treatment adherence in chronic disease.J. Clin. Epidemiol.54 , S57–S60 (2001).
  • Lessells R , MutevedziP, CookeG, NewellM: Retention in HIV care for individuals not yet eligible for antiretroviral therapy: rural KwaZulu Natal, South Africa.J. Acquir Immune Defic. Syndr.56(3) , E79–E86 (2011).

Websites

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.